Filing Flows

Filing Flows › Metagenomi Therapeutics (MGX) › Who owns the stock

Who owns Metagenomi Therapeutics (MGX) stock

44 funds reported Metagenomi Therapeutics (MGX) shares in their latest 13F filings, worth $10.6M in all. The largest holder is Vanguard Group ($2.1M). Last quarter 15 funds added to their stakes and 20 cut them.

Largest holders of MGX (13F)Largest holders of MGX (13F)Vanguard Group$2.1MSozo Ventures GP II, L.P.$1.3MVanguard Capital Management LLC$1.3MRenaissance Technologies LLC$883KCatalio Capital Management, LP$630KTwo Sigma Investments, LP$611KPeapod Lane Capital LLC$520KBridgeway Capital Management, LLC$476KWells Fargo$452KGeode Capital Management, LLC$344K

Largest holders (13F)

FundSharesValueChangeQuarter
Vanguard Group1,270,246$2.1Mincrease2025-12-31
Sozo Ventures GP II, L.P.581,577$1.3Munchanged2025-09-30
Vanguard Capital Management LLC1,077,700$1.3Mincrease2026-06-30
Renaissance Technologies LLC742,400$883Kdecrease2026-06-30
Catalio Capital Management, LP528,993$630Kunchanged2026-06-30
Two Sigma Investments, LP513,701$611Kincrease2026-06-30
Peapod Lane Capital LLC490,992$520Kdecrease2026-09-30
Bridgeway Capital Management, LLC400,300$476Kincrease2026-06-30
Wells Fargo379,508$452Kincrease2026-06-30
Geode Capital Management, LLC288,665$344Kdecrease2026-06-30
BlackRock257,631$307Kincrease2026-06-30
Good Life Advisors, LLC200,000$296Kincrease2025-06-30
Vanguard Fiduciary Trust171,251$204Kincrease2026-06-30
Jacobs Levy Equity Management160,000$190Kdecrease2026-06-30
State Street119,850$143Kdecrease2026-06-30

Metagenomi Therapeutics' latest quarter

Metagenomi Therapeutics, Q1 2026: revenue $1.2M (-70% year over year), net loss $23.1M, operating cash flow −$21.2M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most MGX stock?

By the latest 13F filings: Vanguard Group ($2.1M); Sozo Ventures GP II, L.P. ($1.3M); Vanguard Capital Management LLC ($1.3M); Renaissance Technologies LLC ($883K); Catalio Capital Management, LP ($630K).

What is the short interest in MGX?

1,292,216 shares were sold short at the 2026-10-15 settlement, 1.6% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.